Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pediatrix Medical Group, Inc. (MD) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pediatrix Medical Group, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 893949.
Total stock buying since 2005: $19,890,500.
Total stock sales since 2005: $333,386,299.
Total stock option exercises since 2005: $90,367,220.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 103,808 | $1,255,275 | 0 | $0 |
| 2023 | 0 | $0 | 73,077 | $957,272 | 0 | $0 |
| 2022 | 0 | $0 | 179,137 | $4,023,567 | 0 | $0 |
| 2021 | 0 | $0 | 630,273 | $17,818,757 | 95,000 | $1,676,749 |
| 2020 | 0 | $0 | 132,000 | $2,908,189 | 17,690 | $0 |
| 2019 | 500,000 | $10,760,602 | 40,279 | $1,207,422 | 0 | $0 |
| 2018 | 0 | $0 | 81,751 | $3,806,030 | 73,336 | $1,929,506 |
| 2017 | 21,704 | $1,210,844 | 162,757 | $10,259,627 | 92,194 | $2,844,064 |
| 2016 | 2,100 | $139,681 | 98,933 | $6,732,204 | 88,230 | $2,591,072 |
| 2015 | 0 | $0 | 458,285 | $33,614,325 | 156,122 | $2,954,443 |
| 2014 | 0 | $0 | 1,149,915 | $68,541,738 | 1,046,272 | $26,195,183 |
| 2013 | 0 | $0 | 429,378 | $43,442,311 | 469,284 | $9,058,708 |
| 2012 | 0 | $0 | 465,309 | $34,459,084 | 176,696 | $6,470,295 |
| 2011 | 50,000 | $3,276,450 | 312,849 | $21,970,744 | 203,381 | $7,553,739 |
| 2010 | 0 | $0 | 100,818 | $5,928,177 | 47,516 | $1,370,394 |
| 2009 | 163,460 | $4,502,923 | 711,826 | $38,488,308 | 392,277 | $5,859,618 |
| 2008 | 0 | $0 | 0 | $0 | 69,778 | $1,862,102 |
| 2007 | 0 | $0 | 260,852 | $14,955,055 | 271,516 | $7,605,516 |
| 2006 | 0 | $0 | 272,705 | $21,846,177 | 248,665 | $11,771,271 |
| 2005 | 0 | $0 | 13,566 | $1,172,037 | 10,266 | $624,560 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-10-30 | Medel Roger Md (Chief Executive Officer) | Option Ex | 36,509 | 22.35 | 815,976 |
| 2014-07-30 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 80,000 | 60.00 | 4,800,000 |
| 2014-07-30 | Wagner Karl B (Pres, American Anesthesiology) | Option Ex | 80,000 | 27.87 | 2,229,600 |
| 2014-07-29 | Medel Roger Md (Chief Executive Officer) | Option Ex | 43,580 | .00 | 0 |
| 2014-06-10 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 2,252 | 58.48 | 131,696 |
| 2014-06-06 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 44,596 | 58.53 | 2,610,337 |
| 2014-06-05 | Hawk William C (COO American Anesthesiology) | Sale | 6,911 | 57.66 | 398,488 |
| 2014-06-02 | Stanley Michael D (Pres., Pediatrix Medical Group) | Sale | 18,006 | 57.00 | 1,026,287 |
| 2014-06-02 | Clark David A. (COO, Pediatrix Medical Group) | Sale | 16,230 | 57.00 | 925,093 |
| 2014-06-02 | Calabro Joseph M (President and COO) | Sale | 38,228 | 56.98 | 2,178,116 |
| 2014-05-09 | Goldschmidt, Md Pascal J (Director) | Sale | 30,000 | 57.11 | 1,713,300 |
| 2014-05-09 | Goldschmidt, Md Pascal J (Director) | Option Ex | 30,000 | 23.69 | 710,640 |
| 2014-05-09 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 79,524 | 57.09 | 4,540,422 |
| 2014-05-09 | Wagner Karl B (Pres, American Anesthesiology) | Option Ex | 79,524 | 25.19 | 2,003,050 |
| 2014-05-08 | Calabro Joseph M (President and COO) | Sale | 14,510 | 57.69 | 837,081 |
| 2014-05-08 | Calabro Joseph M (President and COO) | Option Ex | 14,510 | 28.02 | 406,642 |
| 2014-05-07 | Calabro Joseph M (President and COO) | Sale | 122,990 | 56.98 | 7,008,585 |
| 2014-05-07 | Calabro Joseph M (President and COO) | Option Ex | 122,990 | 27.87 | 3,427,731 |
| 2014-02-20 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 3,000 | 61.00 | 183,000 |
| 2014-02-10 | Waldemar, Md Carlo A (Director) | Sale | 10,668 | 55.40 | 591,007 |
| 2014-02-10 | Waldemar, Md Carlo A (Director) | Option Ex | 10,668 | 25.17 | 268,513 |
| 2014-02-10 | Calabro Joseph M (President and COO) | Sale | 87,719 | 55.81 | 4,896,035 |
| 2014-02-10 | Calabro Joseph M (President and COO) | Option Ex | 87,719 | 25.03 | 2,195,869 |
| 2014-02-07 | Calabro Joseph M (President and COO) | Sale | 55,282 | 55.20 | 3,051,511 |
| 2014-02-07 | Calabro Joseph M (President and COO) | Option Ex | 55,282 | 22.35 | 1,235,552 |
| 2014-02-06 | Calabro Joseph M (President and COO) | Sale | 6,999 | 55.03 | 385,175 |
| 2014-02-06 | Calabro Joseph M (President and COO) | Option Ex | 6,999 | 22.35 | 156,427 |
| 2014-02-03 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 9,200 | 55.20 | 507,840 |
| 2013-11-25 | Alvarez Cesar L (Director) | Sale | 16,792 | 110.53 | 1,856,103 |
| 2013-11-25 | Alvarez Cesar L (Director) | Option Ex | 16,792 | 37.56 | 630,707 |
| 2013-11-13 | Medel Roger Md (Chief Executive Officer) | Sale | 200,000 | 110.00 | 22,000,000 |
| 2013-11-13 | Medel Roger Md (Chief Executive Officer) | Option Ex | 200,000 | 30.98 | 6,197,000 |
| 2013-11-07 | Sosa Enrique (Director) | Sale | 5,334 | 107.00 | 570,764 |
| 2013-11-07 | Sosa Enrique (Director) | Option Ex | 5,334 | 50.34 | 268,513 |
| 2013-11-07 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 1,800 | 107.60 | 193,685 |
| 2013-11-07 | Wagner Karl B (Pres, American Anesthesiology) | Option Ex | 1,800 | 44.70 | 80,460 |
| 2013-11-06 | Alvarez Cesar L (Director) | Sale | 8,000 | 108.01 | 864,080 |
| 2013-11-06 | Alvarez Cesar L (Director) | Option Ex | 8,000 | 30.98 | 247,880 |
| 2013-10-30 | Medel Roger Md (Chief Executive Officer) | Option Ex | 21,790 | .00 | 0 |
| 2013-09-11 | Hawk William C (COO American Anesthesiology) | Sale | 3,162 | 100.60 | 318,090 |
| 2013-09-11 | Hawk William C (COO American Anesthesiology) | Option Ex | 1,667 | 44.70 | 74,514 |
| 2013-09-10 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 3,718 | 99.63 | 370,424 |
| 2013-09-10 | Andreano Dominic J (SVP, General Counsel and Secy) | Option Ex | 3,718 | 44.70 | 166,194 |
| 2013-08-20 | Medel Roger Md (Chief Executive Officer) | Option Ex | 100,000 | .00 | 0 |
| 2013-08-07 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 25,000 | 98.01 | 2,450,325 |
| 2013-08-02 | Calabro Joseph M (President and COO) | Sale | 8,446 | 97.81 | 826,069 |
| 2013-08-01 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 345 | 99.90 | 34,465 |
| 2013-08-01 | Andreano Dominic J (SVP, General Counsel and Secy) | Option Ex | 345 | 44.70 | 15,421 |
| 2013-08-01 | Calabro Joseph M (President and COO) | Sale | 27,708 | 98.80 | 2,737,661 |
| 2013-06-11 | Freeman Roger K (Director) | Sale | 275 | 92.65 | 25,479 |
| 2013-06-03 | Stanley Michael D (Pres., Pediatrix Medical Group) | Sale | 8,906 | 91.01 | 810,535 |
| 2013-06-03 | Clark David A. (COO, Pediatrix Medical Group) | Sale | 8,645 | 91.01 | 786,781 |
| 2013-06-03 | Calabro Joseph M (President and COO) | Sale | 19,699 | 91.00 | 1,792,687 |
| 2013-05-01 | Medel Roger Md (Chief Executive Officer) | Option Ex | 21,790 | .00 | 0 |
| 2013-04-02 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 3,500 | 90.00 | 315,000 |
| 2013-03-04 | Medel Roger Md (Chief Executive Officer) | Sale | 72,048 | 84.73 | 6,104,843 |
| 2013-03-04 | Medel Roger Md (Chief Executive Officer) | Option Ex | 72,048 | 12.90 | 929,419 |
| 2013-02-20 | Alvarez Cesar L (Director) | Sale | 8,000 | 87.50 | 700,000 |
| 2013-02-20 | Alvarez Cesar L (Director) | Option Ex | 8,000 | 18.77 | 150,200 |
| 2013-02-01 | Waldemar, Md Carlo A (Director) | Sale | 8,000 | 85.67 | 685,320 |
| 2013-02-01 | Waldemar, Md Carlo A (Director) | Option Ex | 8,000 | 37.30 | 298,400 |
| 2012-12-05 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 10,000 | 79.59 | 795,860 |
| 2012-12-05 | Andreano Dominic J (SVP, General Counsel and Secy) | Option Ex | 10,000 | 32.63 | 326,300 |
| 2012-12-04 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 1,000 | 80.00 | 80,000 |
| 2012-12-04 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 3,700 | 80.00 | 296,000 |
| 2012-11-29 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 24,984 | 78.90 | 1,971,212 |
| 2012-11-23 | Stanley Michael D (President, Pediatrix Division) | Sale | 1,470 | 77.16 | 113,426 |
| 2012-11-23 | Stanley Michael D (President, Pediatrix Division) | Option Ex | 1,470 | 57.09 | 83,922 |
| 2012-11-23 | Clark David A. (COO, Pediatrix Division) | Sale | 2,019 | 77.16 | 155,792 |
| 2012-11-23 | Clark David A. (COO, Pediatrix Division) | Option Ex | 2,019 | 57.09 | 115,264 |
| 2012-11-21 | Fernandez Michael (Director) | Sale | 12,931 | 76.50 | 989,247 |
| 2012-11-20 | Stanley Michael D (President, Pediatrix Division) | Sale | 400 | 77.09 | 30,838 |
| 2012-11-20 | Stanley Michael D (President, Pediatrix Division) | Option Ex | 400 | 57.09 | 22,836 |
| 2012-11-20 | Clark David A. (COO, Pediatrix Division) | Sale | 600 | 77.10 | 46,258 |
| 2012-11-20 | Clark David A. (COO, Pediatrix Division) | Option Ex | 600 | 57.09 | 34,254 |
| 2012-11-16 | Medel Roger Md (Chief Executive Officer) | Sale | 50,000 | 73.65 | 3,682,550 |
| 2012-11-16 | Medel Roger Md (Chief Executive Officer) | Option Ex | 50,000 | 19.92 | 996,000 |
| 2012-11-09 | Sosa Enrique (Director) | Sale | 8,000 | 76.12 | 608,992 |
| 2012-11-09 | Sosa Enrique (Director) | Option Ex | 8,000 | 37.30 | 298,400 |
| 2012-11-08 | Freeman Roger K (Director) | Sale | 14,926 | 75.77 | 1,130,913 |
| 2012-11-08 | Freeman Roger K (Director) | Option Ex | 14,126 | 44.08 | 622,674 |
| 2012-11-07 | Stanley Michael D (President, Pediatrix Division) | Sale | 9,755 | 77.11 | 752,256 |
| 2012-11-07 | Stanley Michael D (President, Pediatrix Division) | Option Ex | 9,755 | 57.09 | 556,912 |
| 2012-11-07 | Clark David A. (COO, Pediatrix Division) | Sale | 9,881 | 77.12 | 762,012 |
| 2012-11-07 | Clark David A. (COO, Pediatrix Division) | Option Ex | 9,881 | 57.09 | 564,106 |
| 2012-11-06 | Fernandez Michael (Director) | Sale | 20,000 | 75.00 | 1,500,000 |
| 2012-11-02 | Fernandez Michael (Director) | Sale | 20,000 | 74.44 | 1,488,820 |
| 2012-09-11 | Goldschmidt, Md Pascal J (Director) | Sale | 8,792 | 72.59 | 638,193 |
| 2012-09-11 | Goldschmidt, Md Pascal J (Director) | Option Ex | 8,792 | 37.82 | 332,513 |
| 2012-08-16 | Andreano Dominic J (SVP, General Counsel and Secy) | Sale | 1,162 | 69.80 | 81,107 |
| 2012-06-01 | Stanley Michael D (President, Pediatrix Division) | Sale | 8,649 | 59.89 | 517,997 |
| 2012-06-01 | Clark David A. (COO, Pediatrix Division) | Sale | 9,152 | 59.89 | 548,149 |
| 2012-06-01 | Calabro Joseph M (Chief Operating Officer) | Sale | 16,641 | 59.89 | 996,579 |
| 2012-02-28 | Medel Roger Md (Chief Executive Officer) | Sale | 100,000 | 74.61 | 7,460,899 |
| 2012-02-27 | Stanley Michael D (President, Pediatrix Division) | Sale | 4,053 | 75.50 | 306,001 |
| 2012-02-27 | Stanley Michael D (President, Pediatrix Division) | Option Ex | 4,053 | 55.43 | 224,657 |
| 2012-02-27 | Clark David A. (COO / Pediatrix Division) | Sale | 4,100 | 75.50 | 309,562 |
| 2012-02-27 | Clark David A. (COO / Pediatrix Division) | Option Ex | 4,100 | 55.43 | 227,263 |
| 2012-02-24 | Stanley Michael D (President, Pediatrix Division) | Sale | 9,800 | 75.45 | 739,439 |
| 2012-02-24 | Stanley Michael D (President, Pediatrix Division) | Option Ex | 9,800 | 55.43 | 543,214 |
| 2012-02-24 | Clark David A. (COO / Pediatrix Division) | Sale | 9,700 | 75.45 | 731,903 |
| 2012-02-24 | Clark David A. (COO / Pediatrix Division) | Option Ex | 9,700 | 55.43 | 537,671 |
| 2012-02-21 | Hawkins Thomas W (SVP, General Counsel and Secy.) | Sale | 3,600 | 74.84 | 269,431 |
| 2012-02-17 | Calabro Joseph M (Chief Operating Officer) | Sale | 2,479 | 75.02 | 185,977 |
| 2012-02-17 | Hawkins Thomas W (SVP, General Counsel and Secy.) | Sale | 14,373 | 74.75 | 1,074,424 |
| 2012-02-16 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 4,500 | 75.00 | 337,500 |
| 2012-02-16 | Sosa Enrique (Director) | Sale | 20,000 | 75.07 | 1,501,399 |
| 2012-02-16 | Sosa Enrique (Director) | Option Ex | 20,000 | 30.98 | 619,700 |
| 2012-02-16 | Calabro Joseph M (Chief Operating Officer) | Sale | 44,642 | 75.03 | 3,349,489 |
| 2012-02-09 | Alvarez Cesar L (Director) | Sale | 6,000 | 72.21 | 433,259 |
| 2012-02-09 | Alvarez Cesar L (Director) | Option Ex | 6,000 | 19.45 | 116,729 |
| 2012-02-03 | Waldemar, Md Carlo A (Director) | Sale | 8,000 | 71.70 | 573,600 |
| 2012-02-03 | Waldemar, Md Carlo A (Director) | Option Ex | 8,000 | 30.98 | 247,880 |
| 2011-11-08 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 25,000 | 69.72 | 1,743,025 |
| 2011-09-19 | Medel Roger Md (Chief Executive Officer) | Sale | 50,000 | 64.84 | 3,241,899 |
| 2011-09-19 | Medel Roger Md (Chief Executive Officer) | Option Ex | 50,000 | 18.15 | 907,499 |
| 2011-08-17 | Alvarez Cesar L (Director) | Sale | 30,000 | 65.25 | 1,957,620 |
| 2011-08-17 | Alvarez Cesar L (Director) | Option Ex | 30,000 | 13.51 | 405,150 |
| 2011-08-04 | Fernandez Michael (Director) | Buy | 50,000 | 65.53 | 3,276,450 |
| 2011-06-10 | Miller Frederick V Md (President, Pediatrix Division) | Sale | 10,168 | 69.41 | 705,771 |
| 2011-06-08 | Hawkins Thomas W (SVP, General Counsel and Secy.) | Sale | 21,286 | 69.69 | 1,483,400 |
| 2011-06-02 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 465 | 74.56 | 34,670 |
| 2011-06-02 | Clark David A. (COO / Pediatrix Division) | Sale | 8,188 | 73.62 | 602,792 |
| 2011-06-02 | Miller Frederick V Md (President, Pediatrix Division) | Sale | 5,833 | 73.61 | 429,390 |
| 2011-06-01 | Miller Frederick V Md (President, Pediatrix Division) | Option Ex | 5,833 | 55.43 | 323,323 |
| 2011-06-01 | Calabro Joseph M (President and COO) | Sale | 15,590 | 73.65 | 1,148,250 |
| 2011-05-20 | Clark David A. (COO / Pediatrix Division) | Sale | 1,200 | 75.44 | 90,528 |
| 2011-05-20 | Clark David A. (COO / Pediatrix Division) | Option Ex | 1,200 | 55.43 | 66,516 |
| 2011-05-17 | Hawkins Thomas W (SVP, General Counsel and Secy.) | Sale | 81,250 | 73.69 | 5,987,312 |
| 2011-05-17 | Hawkins Thomas W (SVP, General Counsel and Secy.) | Option Ex | 81,250 | 52.06 | 4,229,875 |
| 2011-05-04 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 1,850 | 72.00 | 133,200 |
| 2011-05-04 | Wagner Karl B (Pres, American Anesthesiology) | Sale | 29,852 | 72.02 | 2,149,941 |
| 2011-05-03 | Miller Frederick V Md (President, Pediatrix Division) | Sale | 12,500 | 72.40 | 905,000 |
| 2011-05-03 | Miller Frederick V Md (President, Pediatrix Division) | Option Ex | 12,500 | 57.09 | 713,625 |
| 2011-04-28 | Miller Frederick V Md (President, Pediatrix Division) | Sale | 10,482 | 70.44 | 738,341 |
| 2011-04-28 | Miller Frederick V Md (President, Pediatrix Division) | Option Ex | 10,482 | 55.43 | 581,017 |
| 2011-04-06 | Miller Frederick V Md (President, Pediatrix Division) | Sale | 1,185 | 70.44 | 83,469 |
| 2011-04-06 | Miller Frederick V Md (President, Pediatrix Division) | Option Ex | 1,185 | 55.43 | 65,684 |
| 2011-03-10 | Waldemar, Md Carlo A (Director) | Sale | 8,000 | 67.02 | 536,136 |
| 2011-03-10 | Waldemar, Md Carlo A (Director) | Option Ex | 8,000 | 18.77 | 150,200 |
| 2011-02-15 | Fernandez Michael (Director) | Option Ex | 2,931 | 37.82 | 110,850 |
| 2010-12-10 | Clark David A. (COO / Pediatrix Division) | Sale | 7,456 | 64.75 | 482,768 |
| 2010-12-10 | Clark David A. (COO / Pediatrix Division) | Option Ex | 7,456 | 44.70 | 333,283 |
| 2010-12-02 | Clark David A. (COO / Pediatrix Division) | Sale | 2,960 | 64.72 | 191,565 |
| 2010-12-02 | Clark David A. (COO / Pediatrix Division) | Option Ex | 2,960 | 44.70 | 132,312 |
| 2010-11-04 | Lopez-blanco Vivian (Chief Financial Officer) | Sale | 5,550 | 61.50 | 341,325 |
| 2010-06-03 | Calabro Joseph M (President and COO) | Sale | 32,019 | 58.06 | 1,859,151 |
| 2010-06-02 | Hawkins Thomas W (SVP, General Counsel and Secy.) | Sale | 16,664 | 56.83 | 947,048 |
| 2010-06-01 | Clark David A. (COO / Pediatrix Division) | Sale | 6,755 | 55.95 | 377,908 |
| 2010-06-01 | Miller Frederick V Md (President, Pediatrix Division) | Sale | 8,267 | 55.95 | 462,497 |
Insider trading activities including stock purchases, stock sales, and option exercises of MD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pediatrix Medical Group, Inc. (symbol MD, CIK number 893949) see the Securities and Exchange Commission (SEC) website.